ResMed announced today that it launched its new AirTouch N30i continuous positive airway pressure (CPAP) mask.

on Thursday classified a product recall initiated by ResMed (NYSE:RMD) for its respiratory care devices, AirFit and AirTouch masks, as a Class I recall, the most serious type. The agency said the ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

Implemented in 2023, ResMed’s 2030 Operating Model reorganized the company to ensure it remains product-led, customer-centric, and brand-enhanced. The 2030 Operating Model further accelerates ResMed’s ...

“New commercial excellence and demand generation initiatives will drive more patients into ResMed’s funnel, where they will be served by a robust road map of new products, such as the AirTouch ...

And although manufacturers provide a ton of specifications and customizations — upholstery material, cushion-fill material, Martindale rating, the style of the joinery and springs — it can ...

In a report released today, Lyanne Harrison from Bank of America Securities maintained a Buy rating on Resmed (RMD – Research Report). The company’s shares opened today at $245.37. According ...

ResMed Inc.’s RMD growth is backed by its ... The company has successfully introduced a full suite of masks in its AirFit and, AirTouch and other ranges. It continues to witness strong growth ...

SEI Large Cap(SIMT) Fund earns a Below Average Process Pillar rating. The process is strengthened by the parent firm's five-year risk-adjusted success ratio of 63%. The measure indicates the ...

NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and shareholder returns at an Investor Day ...